📰 Philipp Mathieu News
Page 4 - Philipp Mathieu News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Philipp Mathieu. Real-time updates on events, politics, business and more.
December 5, 2022
/PRNewswire/ -- Immunovia (Nasdaq Stockholm: IMMNOV), the diagnostics company that has launched the worlds first blood test dedicated to the early detection...
November 30, 2022
/PRNewswire/ -- Immunovia (Nasdaq Stockholm: IMMNOV) today announced that the Centers for Medicare and Medicaid Services (CMS) has finalized their payment...
November 30, 2022
LUND, Sweden, Nov. 30, 2022 /PRNewswire/ -- Immunovia (Nasdaq Stockholm: IMMNOV) today announced that the Centers for Medicare and Medicaid Services (CMS) has finalized their payment determination
November 16, 2022
LUND, Sweden, Nov. 16, 2022 /PRNewswire/ -- Immunovia AB (NASDAQ: IMMNOV) announces today that Philipp Mathieu, CEO of Immunovia, has purchased 150000 warrants of the 2022/2026 scheme for approximately
November 16, 2022
/PRNewswire/ -- Immunovia AB (NASDAQ: IMMNOV) announces today that Philipp Mathieu, CEO of Immunovia, has purchased 150000 warrants of the 2022/2026 scheme for...
November 10, 2022
/PRNewswire/ -- July-September 2022 Net sales amount KSEK 358 (377) divided by sales of tests KSEK 111 and royalties KSEK 247. Net earnings amount MSEK -23...
November 10, 2022
LUND, Sweden, Nov. 10, 2022 /PRNewswire/ -- July-September 2022 Net sales amount KSEK 358 (377) divided by sales of tests KSEK 111 and royalties KSEK 247.Net earnings amount MSEK
November 3, 2022
/PRNewswire/ -- Immunovia will publish its third quarter 2022 results on November 10, 2022 at 8:30 am CET. Analysts, investors and media are invited to a...
October 20, 2022
LUND, Sweden, Oct. 20, 2022 /PRNewswire/ -- According to the instructions for the Nomination Committee of Immunovia AB (Publ) that were adopted at the Annual General Meeting on April 7, 2022
October 19, 2022
LUND, Sweden, Oct. 19, 2022 /PRNewswire/ -- Immunovia AB (Nasdaq Stockholm: IMMNOV) today announced changes to its executive management team to accelerate the execution of its strategic priorities.